A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

MLA

Holt, Stephen G., et al. “A Consensus Statement on the Renal Monitoring of Australian Patients Receiving Tenofovir Based Antiviral Therapy for HIV/HBV Infection.” AIDS Research & Therapy, vol. 11, Dec. 2014, pp. 1–22. EBSCOhost, https://doi.org/10.1186/1742-6405-11-35.

APA

Holt, S. G., Gracey, D. A., Levy, M. T., Mudge, D. W., Irish, A. B., Walker, R. G., Baer, R., Sevastos, J., Abbas, R., & Boyd, M. A. (2014). A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Research & Therapy, 11, 1–22. https://doi.org/10.1186/1742-6405-11-35

Chicago

Holt, Stephen G., David A. Gracey, Miriam T. Levy, David W. Mudge, Ashley B. Irish, Rowan G. Walker, Richard Baer, Jacob Sevastos, Riaz Abbas, and Mark A. Boyd. 2014. “A Consensus Statement on the Renal Monitoring of Australian Patients Receiving Tenofovir Based Antiviral Therapy for HIV/HBV Infection.” AIDS Research & Therapy 11 (December): 1–22. doi:10.1186/1742-6405-11-35.